文献速递糖尿病

埃塞俄比亚西北部阿姆哈拉地区1型糖尿病的免疫遗传学研究

Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia.
PubMed 文献 · Diabetologia · 2020-07-23

在埃塞俄比亚西北部农村阿姆哈拉人群中,连续纳入236例新诊断胰岛素依赖型糖尿病患者和200名对照,检测C肽、自身抗体和HLA-DRB1等位基因,发现多数患者具有自身免疫性1型糖尿病的免疫遗传特征,但与工业化国家表型差异仍无法解释。

要点

  • 仅15.3%的患者发病年龄≤15岁。
  • 发病年龄≤15、16-25和26-35岁者自身抗体阳性率分别为86.1%、59.7%和50.0%。
  • HLA-DRB1*03:01和HLA-DRB1*04与糖尿病正相关,HLA-DRB1*15有保护作用。

核心结论

  • 埃塞俄比亚西北部农村多数胰岛素依赖型糖尿病患者具有自身免疫性1型糖尿病的免疫遗传特征。
  • 该人群与工业化国家1型糖尿病的表型差异仍无法解释。

研究设计与样本

  • 在埃塞俄比亚西北部农村阿姆哈拉人群中开展连续、非选择性新诊断胰岛素依赖型糖尿病病例(n=236,≤35岁)与对照(n=200)的研究。
  • 检测非空腹C肽、糖尿病相关自身抗体和HLA-DRB1等位基因,并利用全基因组基因分型进行主成分分析和初步全基因组关联研究。
  • 计算1型糖尿病遗传风险评分,以比较其遗传背景与已知欧洲1型糖尿病决定因素。

主要发现

  • 患者表现为生长迟缓、低BMI和胰岛素敏感,仅15.3%在≤15岁发病。
  • C肽水平低但未完全缺失。
  • 临床发病年龄≤15、16-25和26-35岁者自身抗体阳性率分别为86.1%、59.7%和50.0%。
  • 多数患者仅有GAD自身抗体(GADA)单一抗体,IA-2自身抗体(IA-2A)和ZnT8自身抗体(ZnT8A)阳性率在所有年龄组均低。
  • HLA-DRB1*03:01(p=0.0014)和HLA-DRB1*04(p=0.0001)与糖尿病正相关,HLA-DRB1*15有保护作用(p<0.0001);患者平均1型糖尿病遗传风险评分高于对照(p=1.60×10-7)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We aimed to characterise the immunogenic background of insulin-dependent diabetes in a resource-poor rural African community. The study was initiated because reports of low autoantibody prevalence and phenotypic differences from European-origin cases with type 1 diabetes have raised doubts as to the role of autoimmunity in this and similar populations. METHODS: A study of consecutive, unselected cases of recently diagnosed, insulin-dependent diabetes (n = 236, ≤35 years) and control participants (n = 200) was carried out in the ethnic Amhara of rural North-West Ethiopia. We assessed their demographic and socioeconomic characteristics, and measured non-fasting C-peptide, diabetes-associated autoantibodies and HLA-DRB1 alleles. Leveraging genome-wide genotyping, we performed both a principal component analysis and, given the relatively modest sample size, a provisional genome-wide association study. Type 1 diabetes genetic risk scores were calculated to compare their genetic background with known European type 1 diabetes determinants. RESULTS: Patients presented with stunted growth and low BMI, and were insulin sensitive; only 15.3% had diabetes onset at ≤15 years. C-peptide levels were low but not absent. With clinical diabetes onset at ≤15, 16-25 and 26-35 years, 86.1%, 59.7% and 50.0% were autoantibody positive, respectively. Most had autoantibodies to GAD (GADA) as a single antibody; the prevalence of positivity for autoantibodies to IA-2 (IA-2A) and ZnT8 (ZnT8A) was low in all age groups. Principal component analysis showed that the Amhara genomes were distinct from modern European and other African genomes. HLA-DRB1*03:01 (p = 0.0014) and HLA-DRB1*04 (p = 0.0001) were positively associated with this form of diabetes, while HLA-DRB1*15 was protective (p < 0.0001). The mean type 1 diabetes genetic risk score (derived from European data) was higher in patients than control participants (p = 1.60 × 10-7). Interestingly, despite the modest sample size, autoantibody-positive patients revealed evidence of association with SNPs in the well-characterised MHC region, already known to explain half of type 1 diabetes heritability in Europeans. CONCLUSIONS/INTERPRETATION: The majority of patients with insulin-dependent diabetes in rural North-West Ethiopia have the immunogenetic characteristics of autoimmune type 1 diabetes. Phenotypic differences between type 1 diabetes in rural North-West Ethiopia and the industrialised world remain unexplained.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Balcha SA, Demisse AG, Mishra R, et al. Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia. Diabetologia. 2020. PMID: 32705316. doi:10.1007/s00125-020-05229-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。